Mutations in RAS proteins initiate many of the most aggressive tumors, and the search for …
Read More »
INDIANAPOLIS, Nov. 14, 2018 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) has announced the submission of a New Drug …
Read More »
WALTHAM, Mass., Nov. 14, 2018 /PRNewswire/ — Dragonfly Therapeutics, Inc. (“Dragonfly” or the “Company”), today …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
GENEVA, Switzerland, 15 April 2016 – The benefit of plasma genotyping to predict treatment benefit …
Read More »
BARCELONA, April 15, 2016 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced …
Read More »
GENEVA & CAMBRIDGE, Mass.–(BUSINESS WIRE)–ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced updated clinical data on …
Read More »
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cydan Development, Inc., an orphan drug accelerator dedicated to creating therapies that improves …
Read More »
MADISON, N.J., April 14, 2016 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider …
Read More »
PARSIPPANY, NJ, April 14, 2016 – Total spending on medicines in the U.S. reached $310 …
Read More »
April 13, 2016, Barcelona, Spain: A combined vaccination against Hepatitis C virus (HCV) and HIV …
Read More »
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …
Read More »
New options in treating – and curing – almost all cases of hepatitis C infection …
Read More »
VANCOUVER, British Columbia, April 12, 2016 /PRNewswire-USNewswire/ — A common antihistamine used to treat symptoms …
Read More »
TARRYTOWN, N.Y. and CAMBRIDGE, Mass., April 11, 2016 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) …
Read More »
NORTH CHICAGO, Ill., April 11, 2016 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, …
Read More »
SAN DIEGO, April 7, 2016 /PRNewswire/ — Prometheus Laboratories Inc. announced today that the PROMETHEUS …
Read More »
NEW YORK–(BUSINESS WIRE)–Flatiron Health today announced an expansion of its relationships with Celgene Corporation and …
Read More »
BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology, Inc. (NASDAQ: CLVS) announced today that the U.S. Food and Drug …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
